Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTICYTOPLASMIC ANTIBODY - ANVISA Registration 80944340039

Access comprehensive regulatory information for ANTICYTOPLASMIC ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80944340039 and manufactured by IMMCO DIAGNOSTICS, INC.. The registration is held by TRINITY BIOTECH DO BRASIL COMÉRCIO E IMPORTAÇÃO LTDA. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, INOVA DIAGNOSTICS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80944340039
Registration Details
ANVISA Registration Number: 80944340039
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

ImmuLisa ANCA Screen ELISA
Risk Class II

Registration Details

80944340039

25351039682201918

15648426000123

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

May 06, 2019

VIGENTE

09/18/2025 19:00:01